21 related articles for article (PubMed ID: 10568835)
1. Large diversity in transport-mediated methotrexate resistance in human leukemia cell line CCRF-CEM established in a high concentration of leucovorin.
Asai S; Miyachi H; Kobayashi H; Takemura Y; Ando Y
Cancer Sci; 2003 Feb; 94(2):210-4. PubMed ID: 12708499
[TBL] [Abstract][Full Text] [Related]
2. Growth suppression of four cancer cells by hyperbaric nitrous oxide and methotrexate.
Jung CH; Sim JY; Ahn W
Korean J Anesthesiol; 2010 Jan; 58(1):61-9. PubMed ID: 20498814
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic modeling of chemotherapeutic effects: application of a transit compartment model to characterize methotrexate effects in vitro.
Lobo ED; Balthasar JP
AAPS PharmSci; 2002; 4(4):E42. PubMed ID: 12646013
[TBL] [Abstract][Full Text] [Related]
4. Letter: 'No first among equals'.
Arora U; Kedia S; Travis S; Ahuja V
Aliment Pharmacol Ther; 2024 Jan; 59(1):144. PubMed ID: 37920121
[No Abstract] [Full Text] [Related]
5. Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines.
Giudice S; Benassi L; Bertazzoni G; Veratti E; Morini D; Azzoni P; Costi MP; Venturelli A; Pirondi S; Seidenari S; Magnoni C
Invest New Drugs; 2012 Aug; 30(4):1484-92. PubMed ID: 21881917
[TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines.
McGuire JJ; Magee KJ; Russell CA; Canestrari JM
Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499
[TBL] [Abstract][Full Text] [Related]
7. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
8. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization.
McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H
Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096
[TBL] [Abstract][Full Text] [Related]
9. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
[TBL] [Abstract][Full Text] [Related]
10. AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies.
Webber S; Bartlett CA; Boritzki TJ; Hillard JA; Howland EF; Johnston AL; Kosa M; Margosiak SA; Morse CA; Shetty BV
Cancer Chemother Pharmacol; 1996; 37(6):509-17. PubMed ID: 8612303
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the effect of AG337, a novel lipophilic thymidylate synthase inhibitor, on human head and neck and human leukemia cell lines.
McGuire JJ; Canestrari JG; Nagel GS
Int J Oncol; 1999 Dec; 15(6):1245-50. PubMed ID: 10568835
[TBL] [Abstract][Full Text] [Related]
12. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
Banerjee D; Mayer-Kuckuk P; Capiaux G; Budak-Alpdogan T; Gorlick R; Bertino JR
Biochim Biophys Acta; 2002 Jul; 1587(2-3):164-73. PubMed ID: 12084458
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]